Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 1979 | 1994 | |||||||||
|
phosphofructokinase, liver type | 0.722 | 0.269 | 2.7E-17 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
expanded repeat domain, CAG/CTG 1 | 0.736 | 0.154 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 1998 | 1998 | |||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha5 | 0.621 | 0.385 | 0.91 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
interleukin 9 receptor | 0.659 | 0.654 | 2.7E-22 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
group | 0.330 | None | 1.000 | 4 | 0 | 1994 | 2000 | ||||||||
|
monoamine oxidase B | 0.533 | 0.808 | 1.00 |
|
group | 0.320 | None | 0.667 | 3 | 0 | 1997 | 2000 | ||||||||
|
dual specificity phosphatase 6 | 0.511 | 0.846 | 0.98 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 0.529 | 0.808 | 1.00 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2001 | 2002 | ||||||||
|
phospholipase A2 group IB | 0.468 | 0.846 | 1.0E-10 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 1996 | 2003 | ||||||||
|
G protein subunit beta 3 | 0.518 | 0.808 | 3.3E-11 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2001 | 2003 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha6 | 0.678 | 0.423 | 1.3E-12 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha1 | 0.563 | 0.577 | 0.91 |
|
group | 0.340 | None | 0.750 | 4 | 0 | 1998 | 2004 | ||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2001 | 2004 | |||||||||
|
discs large MAGUK scaffold protein 3 | 0.544 | 0.615 | 1.00 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2004 | 2005 | ||||||||
|
cholinergic receptor muscarinic 2 | 0.585 | 0.615 | 0.18 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
corticotropin releasing hormone receptor 2 | 0.584 | 0.731 | 8.5E-17 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2002 | 2006 | ||||||||
|
adrenoceptor beta 1 | 0.555 | 0.769 | 2.9E-06 |
|
group | 0.310 | None | 0.500 | 2 | 0 | 2003 | 2006 | ||||||||
|
neuropeptide Y receptor Y2 | 0.612 | 0.577 | 3.6E-02 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2001 | 2006 | ||||||||
|
adrenoceptor alpha 2A | 0.578 | 0.615 | 8.2E-04 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 1998 | 2006 | ||||||||
|
adrenoceptor alpha 1B | 0.686 | 0.500 | 0.14 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
adenosine A2a receptor | 0.526 | 0.769 | 0.60 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
adrenoceptor alpha 2C | 0.682 | 0.346 | 0.50 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 1993 | 2007 |